M Harvie

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. ncbi request reprint Acceptability and tolerance of a low tyrosine and phenylalanine diet in patients with advanced cancer -- a pilot study
    Michelle N Harvie
    University Department of Medical Oncology, South Manchester University Hospitals NHS Trust, Manchester, UK
    J Hum Nutr Diet 15:193-202. 2002
  2. ncbi request reprint Central obesity and breast cancer risk: a systematic review
    M Harvie
    University Departments of Medical Oncology, South Manchester University Hospitals, Manchester, UK
    Obes Rev 4:157-73. 2003
  3. ncbi request reprint Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy
    M N Harvie
    University Departments of Anaesthesia Medical Oncology Surgery, South Manchester University Hospitals NHS Trust, Manchester M20 2LR, UK
    J Hum Nutr Diet 16:323-6. 2003
  4. pmc Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study
    M N Harvie
    Cancer Research UK Department of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, UK
    Br J Cancer 92:673-80. 2005
  5. ncbi request reprint Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention
    M Harvie
    CRUK University Department of Medical Oncology, Christie Hospital, Manchester, UK
    Obes Rev 7:33-47. 2006
  6. ncbi request reprint Energy balance in early breast cancer patients receiving adjuvant chemotherapy
    Michelle N Harvie
    University Department of Medical Oncology, South Manchester University Hospitals NHS Trust, Manchester, UK
    Breast Cancer Res Treat 83:201-10. 2004
  7. ncbi request reprint Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study
    Michelle N Harvie
    Breast Cancer Prevention Centre, South Manchester University Hospitals NHS Trust, Manchester M20 2LR, UK
    Fam Cancer 6:287-94. 2007
  8. ncbi request reprint Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactions
    Anthony Howell
    Dept of Medical Oncology, University of Manchester, Christie Hospital, Withington, UK
    Nat Clin Pract Oncol 2:635-46. 2005

Detail Information

Publications8

  1. ncbi request reprint Acceptability and tolerance of a low tyrosine and phenylalanine diet in patients with advanced cancer -- a pilot study
    Michelle N Harvie
    University Department of Medical Oncology, South Manchester University Hospitals NHS Trust, Manchester, UK
    J Hum Nutr Diet 15:193-202. 2002
    ..Low phenylalanine (phe) and tyrosine (tyr) diets limit tumour growth in animal models and may offer a novel cancer therapy. We studied the efficacy and acceptability of a low phe and tyr diet in patients with advanced cancer...
  2. ncbi request reprint Central obesity and breast cancer risk: a systematic review
    M Harvie
    University Departments of Medical Oncology, South Manchester University Hospitals, Manchester, UK
    Obes Rev 4:157-73. 2003
    ..Amongst pre-menopausal women, central (not general) obesity may be specifically associated with an increased risk of breast cancer...
  3. ncbi request reprint Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy
    M N Harvie
    University Departments of Anaesthesia Medical Oncology Surgery, South Manchester University Hospitals NHS Trust, Manchester M20 2LR, UK
    J Hum Nutr Diet 16:323-6. 2003
    ..Men with nonsmall cell lung cancer (NSCLC) are more susceptible to weight loss than women. The composition and aetiology of these gender specific weight changes are not known...
  4. pmc Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study
    M N Harvie
    Cancer Research UK Department of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, UK
    Br J Cancer 92:673-80. 2005
    ..01) and metastatic breast cancer (Rs=0.617; P<0.05). The ability to meet or exceed energy requirements led to gains in body fat among patients with metastatic breast cancer and NSCLC, but did not prevent loss of FFM in these groups...
  5. ncbi request reprint Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention
    M Harvie
    CRUK University Department of Medical Oncology, Christie Hospital, Manchester, UK
    Obes Rev 7:33-47. 2006
    ..Intermittent energy restriction may be a potential strategy for the primary prevention of breast cancer...
  6. ncbi request reprint Energy balance in early breast cancer patients receiving adjuvant chemotherapy
    Michelle N Harvie
    University Department of Medical Oncology, South Manchester University Hospitals NHS Trust, Manchester, UK
    Breast Cancer Res Treat 83:201-10. 2004
    ..Since weight gain impacts on survival, patients should be counselled to reduce energy intake and exercise during and after adjuvant treatment...
  7. ncbi request reprint Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study
    Michelle N Harvie
    Breast Cancer Prevention Centre, South Manchester University Hospitals NHS Trust, Manchester M20 2LR, UK
    Fam Cancer 6:287-94. 2007
    ..85; odds ratio (95% CI) = 1.42 (1.01-2.01) (p = 0.044). Significant weight gain between the ages of 20 and 40 and the prevalence of central obesity amongst FH women suggest the need for weight management within FH clinics...
  8. ncbi request reprint Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactions
    Anthony Howell
    Dept of Medical Oncology, University of Manchester, Christie Hospital, Withington, UK
    Nat Clin Pract Oncol 2:635-46. 2005
    ..New approaches are required, however, not only to prevent the disease but to devise methods for their assessment that do not require very large and expensive clinical trials...